Structural determinants for activity of the antidepressant vortioxetine at human and rodent 5-HT
Journal
Nature structural & molecular biology
ISSN: 1545-9985
Titre abrégé: Nat Struct Mol Biol
Pays: United States
ID NLM: 101186374
Informations de publication
Date de publication:
02 May 2024
02 May 2024
Historique:
received:
13
12
2022
accepted:
19
03
2024
medline:
3
5
2024
pubmed:
3
5
2024
entrez:
2
5
2024
Statut:
aheadofprint
Résumé
Vortioxetine (VTX) is a recently approved antidepressant that targets a variety of serotonin receptors. Here, we investigate the drug's molecular mechanism of operation at the serotonin 5-HT
Identifiants
pubmed: 38698207
doi: 10.1038/s41594-024-01282-x
pii: 10.1038/s41594-024-01282-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.
Références
Bang-Andersen, B. et al. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. J. Med. Chem. 54, 3206–3221 (2011).
doi: 10.1021/jm101459g
pubmed: 21486038
Sanchez, C., Asin, K. E. & Artigas, F. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Pharmacol. Ther. 145, 43–57 (2015).
doi: 10.1016/j.pharmthera.2014.07.001
pubmed: 25016186
Nackenoff, A. G. et al. Serotonin transporter-independent actions of the antidepressant vortioxetine as revealed using the SERT Met172 mouse. ACS Chem. Neurosci. 8, 1092–1100 (2017).
doi: 10.1021/acschemneuro.7b00038
pubmed: 28272863
Mahableshwarkar, A. R., Zajecka, J., Jacobson, W., Chen, Y. & Keefe, R. S. A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology 41, 2961 (2016).
doi: 10.1038/npp.2016.181
pubmed: 27725683
pmcid: 5061887
McIntyre, R. S., Lophaven, S. & Olsen, C. K. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int. J. Neuropsychopharmacol. 17, 1557–1567 (2014).
doi: 10.1017/S1461145714000546
pubmed: 24787143
Pehrson, A. L. et al. Treatment of cognitive dysfunction in major depressive disorder—a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine. Eur. J. Pharmacol. 753, 19–31 (2015).
doi: 10.1016/j.ejphar.2014.07.044
pubmed: 25107284
Riga, M. S., Sánchez, C., Celada, P. & Artigas, F. Involvement of 5-HT 3 receptors in the action of vortioxetine in rat brain: focus on glutamatergic and GABAergic neurotransmission. Neuropharmacology 108, 73–81 (2016).
doi: 10.1016/j.neuropharm.2016.04.023
pubmed: 27106166
Nemecz, À., Prevost, M. S., Menny, A. & Corringer, P.-J. Emerging molecular mechanisms of signal transduction in pentameric ligand-gated ion channels. Neuron 90, 452–470 (2016).
doi: 10.1016/j.neuron.2016.03.032
pubmed: 27151638
Barnes, N. M. et al. International Union of Basic and Clinical Pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function. Pharmacol. Rev. 73, 310–520 (2021).
doi: 10.1124/pr.118.015552
pubmed: 33370241
pmcid: 7770494
Niesler, B. 5-HT3 receptors: potential of individual isoforms for personalised therapy. Curr. Opin. Pharmacol. 11, 81–86 (2011).
doi: 10.1016/j.coph.2011.01.011
pubmed: 21345729
Ladefoged, L. K. et al. Modeling and mutational analysis of the binding mode for the multimodal antidepressant drug vortioxetine to the human 5-HT3A receptor. Mol. Pharmacol. 94, 1421–1434 (2018).
doi: 10.1124/mol.118.113530
pubmed: 30257860
Polovinkin, L. et al. Conformational transitions of the serotonin 5-HT3 receptor. Nature 563, 275–279 (2018).
doi: 10.1038/s41586-018-0672-3
pubmed: 30401839
pmcid: 6614044
Basak, S. et al. Cryo-EM structure of 5-HT 3A receptor in its resting conformation. Nat. Commun. 9, 514 (2018).
doi: 10.1038/s41467-018-02997-4
pubmed: 29410406
pmcid: 5802770
Basak, S., Gicheru, Y., Rao, S., Sansom, M. S. P. & Chakrapani, S. Cryo-EM reveals two distinct serotonin-bound conformations of full-length 5-HT3A receptor. Nature 563, 270–274 (2018).
doi: 10.1038/s41586-018-0660-7
pubmed: 30401837
pmcid: 6237196
Felt, K. et al. Structural basis for partial agonism in 5-HT3A receptors. Nat. Struct. Mol. Biol. https://doi.org/10.1038/s41594-023-01140-2 (2024).
doi: 10.1038/s41594-023-01140-2
pubmed: 38580848
Zhang, Y. et al. Asymmetric opening of the homopentameric 5-HT 3A serotonin receptor in lipid bilayers. Nat. Commun. 12, 1–15 (2021).
Zarkadas, E. et al. The binding of palonosetron and other antiemetic drugs to the serotonin 5-HT3 receptor. Structure 28, 1131–1140 (2020).
doi: 10.1016/j.str.2020.07.004
pubmed: 32726573
Basak, S. et al. High-resolution structures of multiple 5-HT3AR-setron complexes reveal a novel mechanism of competitive inhibition. eLife 9, e57870 (2020).
doi: 10.7554/eLife.57870
pubmed: 33063666
pmcid: 7655109
Dale, E. et al. The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT3 receptor expressing interneurons: an in vitro study in rat hippocampus slices. Brain Res. 1689, 1–11 (2018).
doi: 10.1016/j.brainres.2017.12.025
pubmed: 29274875
Gielen, M. & Corringer, P.-J. The dual-gate model for pentameric ligand-gated ion channels activation and desensitization. J. Physiol. 596, 1873–1902 (2018).
doi: 10.1113/JP275100
pubmed: 29484660
pmcid: 5978336
Beene, D. L. et al. Cation-pi interactions in ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine. Biochemistry 41, 10262–10269 (2002).
doi: 10.1021/bi020266d
pubmed: 12162741
Xiu, X., Puskar, N. L., Shanata, J. A. P., Lester, H. A. & Dougherty, D. A. Nicotine binding to brain receptors requires a strong cation-pi interaction. Nature 458, 534–537 (2009).
doi: 10.1038/nature07768
pubmed: 19252481
pmcid: 2755585
Thompson, A. J. Recent developments in 5-HT3 receptor pharmacology. Structure 34, 100–109 (2013).
Laverty, D. et al. Cryo-EM structure of the human α1β3γ2 GABAA receptor in a lipid bilayer. Nature 565, 516–520 (2019).
doi: 10.1038/s41586-018-0833-4
pubmed: 30602789
Kim, J. J. et al. Shared structural mechanisms of general anaesthetics and benzodiazepines. Nature 585, 303–308 (2020).
doi: 10.1038/s41586-020-2654-5
pubmed: 32879488
pmcid: 7486282
Talwar, S. & Lynch, J. W. Investigating ion channel conformational changes using voltage clamp fluorometry. Neuropharmacology 98, 3–12 (2015).
doi: 10.1016/j.neuropharm.2015.03.018
pubmed: 25839896
Cowgill, J. & Chanda, B. The contribution of voltage clamp fluorometry to the understanding of channel and transporter mechanisms. J. Gen. Physiol. 151, 1163–1172 (2019).
doi: 10.1085/jgp.201912372
pubmed: 31431491
pmcid: 6785729
Munro, L. et al. Conformational changes in the 5-HT3A receptor extracellular domain measured by voltage-clamp fluorometry. Mol. Pharmacol. 96, 720–734 (2019).
doi: 10.1124/mol.119.116657
pubmed: 31582575
Chang, Y. & Weiss, D. S. Site-specific fluorescence reveals distinct structural changes with GABA receptor activation and antagonism. Nat. Neurosci. 5, 1163–1168 (2002).
doi: 10.1038/nn926
pubmed: 12368804
Lefebvre, S. N., Taly, A., Menny, A., Medjebeur, K. & Corringer, P.-J. Mutational analysis to explore long-range allosteric couplings involved in a pentameric channel receptor pre-activation and activation. eLife 10, e60682 (2021).
doi: 10.7554/eLife.60682
pubmed: 34590583
pmcid: 8504973
Muroi, Y., Czajkowski, C. & Jackson, M. B. Local and global ligand-induced changes in the structure of the GABA(A) receptor. Biochemistry 45, 7013–7022 (2006).
doi: 10.1021/bi060222v
pubmed: 16752892
Pless, S. A. & Lynch, J. W. Ligand-specific conformational changes in the alpha1 glycine receptor ligand-binding domain. J. Biol. Chem. 284, 15847–15856 (2009).
doi: 10.1074/jbc.M809343200
pubmed: 19286654
pmcid: 2708881
Fakhfouri, G., Rahimian, R., Dyhrfjeld-Johnsen, J., Zirak, M. R. & Beaulieu, J.-M. 5-HT3 Receptor antagonists in neurologic and neuropsychiatric disorders: the iceberg still lies beneath the surface. Pharmacol. Rev. 71, 383–412 (2019).
doi: 10.1124/pr.118.015487
pubmed: 31243157
Hassaine, G. et al. Large scale expression and purification of the mouse 5-HT3 receptor. Biochim. Biophys. Acta 1828, 2544–2552 (2013).
doi: 10.1016/j.bbamem.2013.05.028
pubmed: 23747684
Hassaïne, G. et al. Expression, biochemistry, and stabilization with camel antibodies of membrane proteins: case study of the mouse 5-HT3 receptor. Methods Mol. Biol. 1635, 139–168 (2017).
doi: 10.1007/978-1-4939-7151-0_8
pubmed: 28755368
Grychowska, K. et al. Superiority of the triple-acting 5-HT6R/5-HT3R antagonist and MAO-B reversible inhibitor PZ-1922 over 5-HT6R antagonist intepirdine in alleviation of cognitive deficits in rats. J. Med. Chem. 66, 14928–14947 (2023).
doi: 10.1021/acs.jmedchem.3c01482
pubmed: 37797083
Uchański, T. et al. Megabodies expand the nanobody toolkit for protein structure determination by single-particle cryo-EM. Nat. Methods 18, 60–68 (2021).
doi: 10.1038/s41592-020-01001-6
pubmed: 33408403
pmcid: 7611088
Kandiah, E. et al. CM01: a facility for cryo-electron microscopy at the European Synchrotron. Acta Crystallogr D. Struct. Biol. 75, 528–535 (2019).
doi: 10.1107/S2059798319006880
pubmed: 31205015
pmcid: 6580229
Wagner, T. et al. SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Commun. Biol. https://doi.org/10.1038/s42003-019-0437-z (2019).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
doi: 10.1038/nmeth.4169
pubmed: 28165473
Croll, T. I. & Read, R. J. Adaptive Cartesian and torsional restraints for interactive model rebuilding. Acta Crystallogr. D 77, 438–446 (2021).
doi: 10.1107/S2059798321001145
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Biol. Crystallogr. 66, 486–501 (2010).
doi: 10.1107/S0907444910007493
Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D 75, 861–877 (2019).
doi: 10.1107/S2059798319011471
Wu, E. L. et al. CHARMM-GUI Membrane Builder toward realistic biological membrane simulations. J. Comput. Chem. 35, 1997–2004 (2014).
doi: 10.1002/jcc.23702
pubmed: 25130509
pmcid: 4165794
Best, R. B. et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone ϕ, ψ and side-chain χ1 and χ2 dihedral angles. J. Chem. Theory Comput. 8, 3257–3273 (2012).
doi: 10.1021/ct300400x
pubmed: 23341755
pmcid: 3549273
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926–935 (1983).
doi: 10.1063/1.445869
Phillips, J. C. et al. Scalable molecular dynamics on CPU and GPU architectures with NAMD. J. Chem. Phys. 153, 044130 (2020).
doi: 10.1063/5.0014475
pubmed: 32752662
pmcid: 7395834
Feller, S. E., Zhang, Y., Pastor, R. W. & Brooks, B. R. Constant pressure molecular dynamics simulation: the Langevin piston method. J. Chem. Phys. 103, 4613–4621 (1995).
doi: 10.1063/1.470648
Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: an N⋅log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089–10092 (1993).
doi: 10.1063/1.464397
Miyamoto, S. & Kollman, P. A. Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models. J. Comput. Chem. 13, 952–962 (1992).
doi: 10.1002/jcc.540130805
Andersen, H. C. Rattle: A ‘velocity’ version of the shake algorithm for molecular dynamics calculations. J. Comput. Phys. 52, 24–34 (1983).
doi: 10.1016/0021-9991(83)90014-1
Balusek, C. et al. Accelerating membrane simulations with hydrogen mass repartitioning. J. Chem. Theory Comput. 15, 4673–4686 (2019).
doi: 10.1021/acs.jctc.9b00160
pubmed: 31265271
pmcid: 7271963
Tuckerman, M., Berne, B. J. & Martyna, G. J. Reversible multiple time scale molecular dynamics. J. Chem. Phys. 97, 1990–2001 (1992).
doi: 10.1063/1.463137
Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33–38, 27–8 (1996).
Smart, O. S., Neduvelil, J. G., Wang, X., Wallace, B. A. & Sansom, M. S. HOLE: a program for the analysis of the pore dimensions of ion channel structural models. J. Mol. Graph. 14, 354–360, 376 (1996).
doi: 10.1016/S0263-7855(97)00009-X
pubmed: 9195488
Cheng, Y. & Prusoff, W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099–3108 (1973).
doi: 10.1016/0006-2952(73)90196-2
pubmed: 4202581